2-Hydroxy-phenylhydrazin

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-Hydroxy-phenylhydrazin
• 英文别名: 2-Hydrazinylphenol
• 化学式: C₆H₈N₂O
• mdl: MFCD19159474
• 分子量: 124.142
• InChiKey: GCGNGYPZEHFOAN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  58.3
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-Fluoro-4'-cyanochalkon 、 2-Hydroxy-phenylhydrazin 以 乙醇 为溶剂， 生成
  参考文献：
  名称：

  Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles and 1,3,5-trisubstituted pyrazoles as inhibitors of transforming growth factor β type 1 receptor (ALK5)

  摘要：

  Two series of nitrogenous heterocycle compounds-1,2,4-trisubstituted imidazoles and 1,3,5-trisubstituted pyrazoles have been synthesized and evaluated for their ALK5 inhibitory activity and cytotoxicity in TGF beta-Smad2 assay and MTT assay, respectively. The ALK4/5/7 inhibitory activity of some compound was also evaluated in ALK4/5/7 autophosphorylation assays. Compounds 6c and 14c showed relatively potent ALK5 inhibition while weak cytotoxicity. At the same time, compounds 6c and 14c display relatively better ALK5 selectivity versus ALK4/ALK7 (nearly 10-fold) compared with SB431542, a well known ALK5 inhibitor. Compound 6g2 proved to be a moderately selective ALK4 inhibitor versus ALK5 and ALK7 (>10-fold). The binding mode of 14c generated by flexible docking study shows that 14c fits well into the site cavity of ALK5 by forming several tight interactions. (C) 2009 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2009.04.066
• 作为产物：
  描述：

  2-溴苯酚 在 potassium phosphate 、 copper(l) iodide 、 一水合肼 作用下， 反应 10.0h， 生成 2-Hydroxy-phenylhydrazin
  参考文献：
  名称：

  在PEG-400中使用铜催化的芳基卤化物与肼的交叉偶联有效合成芳基肼

  摘要：

  通过铜催化芳基卤化物与肼水溶液在PEG-400中的交叉偶联，描述了一种有效且方便的芳基肼合成方法。该方案适用于缺电子和富电子的芳基碘化物和溴化物，甚至适用于空间受阻的底物，芳基肼的收率良好至极佳。

  DOI：

  10.1016/j.tet.2012.11.014

文献信息

• Regulated activation of cell-membrane receptors by metal-chelating agonists
  申请人：——

  公开号：US20040053299A1

  公开（公告）日：2004-03-18

  Invented is a regulated activation of cell-membrane receptors by small molecule agents. Also invented is a method to render a cell-membrane receptor responsive to the activation by small molecule compounds by specific single point mutations in the transmembrane region.

  发明了通过小分子药剂调节细胞膜受体的激活。还发明了一种方法，通过跨膜区特定的单点突变使细胞膜受体对小分子化合物的激活产生响应。
• [EN] COMPOSITIONS, METHODS OF USE, AND METHODS OF TREATMENT<br/>[FR] COMPOSITIONS, MÉTHODES D'UTILISATION ET MÉTHODES DE TRAITEMENT
  申请人：UNIV NEW ORLEANS

  公开号：WO2015048634A1

  公开（公告）日：2015-04-02

  Embodiments of the present disclosure provide for compositions including an antimicrobial agent, pharmaceutical compositions including the antimicrobial agent, methods of treatment of an infection, methods of treatment using compositions or pharmaceutical compositions, and the like.

  本公开的实施例提供了包括抗微生物剂的组合物、包括抗微生物剂的药物组合物、治疗感染的方法、使用组合物或药物组合物进行治疗的方法等。
• "METHOD FOR PREPARING RAMALIN"
  申请人：Yim Joung Han

  公开号：US20130211133A1

  公开（公告）日：2013-08-15

  The present invention relates to a method for synthesizing ramalin, and more particularly to a method for synthesizing ramalin, which comprises allowing 2-hydrazinylphenol to react with L-glutamic acid having a protected carboxyl group at C-1 and a protected amino group at C-2, and a method for preventing decomposition of the ramalin. According to the present invention, ramalin having excellent antioxidant and anti-inflammatory activities can be synthesized in high yield, and thus can be produced in large amounts. In addition, ramalin can be stably maintained for a long period of time, and thus can be easily used for industrial purposes.

  本发明涉及一种合成拉马林的方法，更具体地涉及一种合成拉马林的方法，包括使2-联苯酚与具有在C-1处保护羧基和在C-2处保护氨基的L-谷氨酸发生反应，并且一种防止拉马林分解的方法。根据本发明，可以高产率地合成具有优异抗氧化和抗炎活性的拉马林，因此可以大量生产。此外，拉马林可以长时间稳定保存，因此可以轻松用于工业用途。
• Novel organic electroluminescent compounds and organic electroluminescent device using the same
  申请人：Gracel Display Inc.

  公开号：EP2062900A1

  公开（公告）日：2009-05-27

  The present invention relates to organic electroluminescent compounds represented by Chemical Formula (1), and electroluminescent devices comprising the same as host material.         Chemical Formula 1     L1L1M The electroluminescent compounds according to the invention, when used as electroluminescent host material in an OLED, provide lowered operation voltage and significantly improved power efficiency as compared to conventional host material.

  本发明涉及化学式（1）所表示的有机电致发光化合物，以及包含它们作为主体材料的电致发光装置。 化学式1 L1L1M 本发明所述的电致发光化合物，在作为OLED的电致发光主体材料时，与传统主体材料相比，可以提供降低操作电压和显著提高功率效率的效果。
• [EN] REGULATED ACTIVATION OF CELL-MEMBRANE RECEPTORS BY METAL-CHELATING AGONISTS<br/>[FR] ACTIVATION REGULEE DES RECEPTEURS DE LA MEMBRANE CELLULAIRE AU MOYEN D'AGONISTES CHELATEURS DES METAUX
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2002057300A1

  公开（公告）日：2002-07-25

  Invented is a regulated activation of cell-membrane receptors by small molecule agents. Also invented is a method to render a cell-membrane receptor responsive to the activation by small molecule compounds by specific single point mutations in the transmembrane region.

  发明了一种通过小分子药物激活细胞膜受体的调节方法。同时，还发明了一种方法，通过跨膜区特定单点突变使细胞膜受体对小分子化合物的激活产生响应。